Folding intermediate characterisation identifies protein species formed during refolding from denatured states. Chaperone protein assistance guides correct folding pathways. Misfolded intermediates aggregating create insoluble species. Kinetic folding studies track structural development. NMR spectroscopy provides residue-level structural information.
Production optimisation prevents misfolding reducing waste. Biophysical characterisation confirms proper folding. Regulatory submissions justify folding processes producing therapeutic proteins. Quality control monitors folding consistency. Emerging technologies enhance folding efficiency.
General Biopharmaceutical Concepts
Folding Intermediate Characterisation
Folding intermediate characterisation identifies and analyses transient protein folding states to better understand protein stability, structure and manufacturing behaviour.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →